Millipore ( and Gen-Probe ( will market and sell the latter’s Mycoplasma Tissue Culture Non-Isotopic (MTC-NI) test to its biopharmaceutical customers. This new agreement expands on the two companies’ existing collaboration to create a new generation of nucleic acid tests.

The MTC-NI assay, developed by Gen-Probe, is a DNA probe-based system that can be combined with Millipore’s sample-preparation products and application knowledge to detect mycoplasma. Millipore’s global sales organization will sell the MTC-NI assay until the new sample-preparation products and higher sensitivity assays that are being developed by the two companies are launched.

Next articleUMMZ Periodical Cicada Page